GATLAN Health Review 2026: Telehealth Pricing, TRT Access, Compounded GLP-1, and Patient Questions
TRT, Semaglutide, Tirzepatide, Hormone Optimization, and Longevity - Is It Worth It? Pricing, Refund Policy, Cancellation Terms, and the Verification Checklist Before You Pay
PLANO, Texas, May 28, 2026 (Newswire.com) - Advertorial Disclosure: This content is a paid advertorial for consumer education and contains affiliate links. A commission may be earned from qualifying actions taken through links in this article, at no additional cost to the reader. This content is not medical advice, does not replace consultation with a licensed healthcare professional, and does not guarantee eligibility for any prescription treatment. Prescription medications require provider evaluation and individual outcomes vary. Disclosure is provided for transparency in accordance with FTC endorsement guidance.
GATLAN Telehealth Review 2026: $269/Month TRT, Compounded GLP-1, and What the December Regulatory Window Means for You - Kyzatrex Pricing, Compounded Medication Access, DEA Telemedicine Rules, and What to Verify Before You Enroll
Disclosure: This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to you. Affiliate relationships don't influence editorial content or how products are evaluated. Disclosure is provided in accordance with FTC 16 CFR Part 255. This content is promotional in nature and is intended for consumer education regarding a commercially available service.
View the current GATLAN offer (official GATLAN page)
GATLAN 2026 Fast Facts: What You Should Know in 30 Seconds
What it is: GATLAN is a direct-to-consumer telehealth platform connecting patients with licensed medical professionals for hormone optimization, metabolic health, and longevity protocols
Legal operator (brand-disclosed): Immortal Male, Inc. | Trademark: GATLAN™ pending (USPTO Serial No. 98635862, Immortal Male, Inc.), 60010 W Spring Creek Pkwy #1012, Plano, TX 75024
Coverage (brand-stated): GATLAN states it covers 44 states - this publication didn't independently verify state-by-state licensure; confirm current availability at gatlan.com
Insurance: The official site states "No insurance required." Prospective patients should confirm whether insurance, HSA, FSA, reimbursement, or other payment options apply to their specific program before enrolling.
Pharmacy partner (brand-disclosed): Epiq Scripts
One publicly stated price: Kyzatrex oral testosterone program - $269 upfront (LabCorp lab draw + provider review + first month medication); $269/month ongoing
Other service pricing: Not publicly posted - requires free consultation
Services (brand-stated): Testosterone-related care, hormone optimization, medical weight management, peptide-related care, NAD+ protocols, hair restoration, men's wellness support, women's hormone support, and longevity-focused care
Chief Medical Advisor (brand-disclosed): Dr. Robert Lufkin, Professor at UCLA and USC School of Medicine
Provider claim (brand-reported): "100% Licensed Providers" - provider credentials are regulated by individual state licensing boards, not independently verified by this publication
Patient count (brand-reported): "10,000+ Patients Optimized"
Compounded medications: Yes - semaglutide and tirzepatide available as compounded formulations through Epiq Scripts; these are not FDA-approved finished drug products
Refund policy (brand-stated): Discretionary - "generally not provided" per published Terms of Service
Minimum age: 18 years old
Start here: GATLAN promotes a free initial consultation as the first step. Treatment eligibility, medication access, and prescription approval are not guaranteed - each depends on provider review, labs, and medical history.
Support: support@gatlan.com
As of: May 2026
FDA enforcement (2026): In March 2026, FDA issued warning letters to 30+ telehealth companies for misleading compounded GLP-1 marketing - GATLAN's published materials don't contain the violations cited; confirm current status before enrolling
FTC enforcement precedent: FTC's December 2025 NextMed consent order redefined hidden-fee disclosure standards for telehealth platforms - what "free consultation" means now has a compliance benchmark
DEA telemedicine window: Online controlled-substance prescribing (including testosterone) permitted without prior in-person visit through December 31, 2026 only - Federal Register doc. 2025-24123; permanent rules pending
DEA telehealth prescribing window: Online TRT prescribing without prior in-person visit permitted through December 31, 2026 only (DEA Fourth Temporary Extension, 90 Fed. Reg. 61301) - permanent rules pending The DEA has explicitly cited the need to prevent a "telemedicine cliff" - the disruption that would result from these flexibilities expiring without permanent replacements.
Trademark status: GATLAN™ pending (USPTO Serial No. 98635862, filed July 7, 2024, owner: Immortal Male, Inc.)
Buyer Takeaway: Two things jump out immediately from GATLAN's Fast Facts: pricing is consultation-gated for most services, which means you'll need the free intake before you can compare it apples-to-apples with other platforms; and compounded medications are central to the weight loss model, which is a buyer-education point worth understanding before you commit to anything.
View the current GATLAN offer (official GATLAN page)
TL;DR - Quick Answer: What Is GATLAN?
GATLAN is a telehealth platform for hormone optimization, medical weight loss, and longevity protocols. The only publicly stated price is $269/month for the Kyzatrex oral testosterone program, which bundles labs, medication, and provider access. Most other pricing is consultation-gated. The brand states it covers 44 states and has served 10,000+ patients (both brand-reported figures). Compounded semaglutide and tirzepatide are part of the weight loss model - and understanding exactly what that means for you is what this review covers before you book.
Quick Verification Snapshot - What's Brand-Stated vs. Publicly Verifiable as of May 2026
Legal operator: Immortal Male, Inc., Plano, TX - published in GATLAN's Terms of Service
Pharmacy partner: Epiq Scripts - published on GATLAN's official hormone optimization page
Kyzatrex pricing: $269/month - published in GATLAN's own support documentation
44-state coverage: Brand-stated in Terms of Service; not independently verified by this publication
Chief Medical Advisor: Dr. Robert Lufkin - named on the official site as Professor at UCLA and USC School of Medicine; faculty affiliations are independently verifiable through university directories
Compounded medication use: Brand-disclosed on the weight loss page; patient testimonials published by GATLAN reference compounded tirzepatide by name
Media coverage: Forbes and Men's Journal named on the homepage; podcast appearances with Adam Carolla, Rich Eisen, Ryan Russillo, The Genius Life, The Skinny Confidential, and Inside of You are listed
Refund policy: "Generally not provided," discretionary - published in Terms of Service
Not publicly stated: GLP-1 pricing, women's path pricing, peptide pricing, shipping costs, Epiq Scripts' 503A vs. 503B classification
Buyer Takeaway: If you're trying to compare GATLAN's costs against Hone, TRT Nation, Hims, or other telehealth platforms right now, you won't have the full picture until you book the free consultation. The Kyzatrex program is the one exception - that price is publicly stated and you can evaluate it today.
What Is GATLAN and How Does It Position Itself?
You've probably seen GATLAN come up in your research if you've been looking into online hormone therapy. Here's what the brand actually says it is, and what that means in practice.
GATLAN describes its model as a "white-glove medical experience" - that's the brand's own language - built around a dedicated licensed medical professional assigned specifically to you. The idea is that instead of a rotating roster of providers or a quick prescription-and-ship transaction, you get one provider who knows your goals, your labs, and your history over time.
The platform is operated by Immortal Male, Inc. and covers 44 states per the brand's own publications. It's entirely online - no in-person office visits, no waiting rooms. Prescriptions, where appropriate, go through Epiq Scripts and get delivered to your door. The brand calls the four-step flow "The GATLAN Experience": intake questionnaire, provider review, personalized plan, ongoing support.
What separates this from the Hims model of the world is the concierge positioning. GATLAN isn't selling you a standardized protocol off a menu. They're selling the relationship - a provider who knows you and adjusts your plan as your labs and goals evolve. Whether that promise holds up in your specific experience is something only you can evaluate, but it's the differentiator they're building around.
Buyer Takeaway: If your priority is the lowest posted monthly rate for a specific medication, GATLAN's consultation-first model may feel like friction. If you want a provider relationship that evolves over time, that's exactly what the model is built for.
What Does GATLAN Offer for Hormone Optimization and Medical Weight Management?
GATLAN offers separate clinical paths for men and women, and the service menu is broader than most single-category TRT or weight loss platforms. Here's what the brand states is available.
Men's path (brand-stated):
Testosterone replacement therapy - including Kyzatrex (FDA-approved oral testosterone) at the publicly stated $269/month; testosterone cypionate (injectable) is also listed on the brand's hormone optimization page
Medical weight loss - compounded semaglutide and tirzepatide through Epiq Scripts
Peptide therapy - listed but not individually priced publicly
NAD+ protocols - listed for cellular health and longevity
Hair restoration - listed as a treatment path
Men's wellness support - listed as a treatment category
Longevity protocols - the brand mentions Rapamycin and NAD+ for what they describe as "cellular housekeeping and repair"
LDN (Low-Dose Naltrexone) - listed on the brand's site as supporting hormonal balance and immune function
Women's path (brand-stated):
Hormone optimization - estrogen and progesterone protocols described on the official women's path page
Medical weight loss - GLP-1 medications listed as available
Thyroid evaluation - included in the women's diagnostic work-up per brand's description
Longevity and wellness support
Every service is subject to provider review and lab evaluation before any prescription is issued. GATLAN's own Terms of Service are explicit that treatment is provided "if appropriate" - signing up doesn't guarantee any specific protocol.
Buyer Takeaway: The breadth here is a real differentiator. Most competitors specialize in one category - TRT or GLP-1 or menopause. GATLAN's menu covers all of it under one provider relationship, which matters if your goals cross categories.
View the current GATLAN offer (official GATLAN page)
How Does GATLAN's Provider-Guided Telehealth Model Work?
Let's walk through the four steps the brand describes, because each one has real implications for your timeline and cost.
Step 1 - Medical Intake. You fill out a guided health history questionnaire from home. It's the first data collection point, and GATLAN's Terms are clear: the accuracy of what you submit directly affects the quality of any medical guidance you receive. You must be 18 or older to register.
Step 2 - Provider Review. A licensed medical professional reviews your intake and decides whether lab work is needed. For the Kyzatrex program specifically, labs are done at a LabCorp walk-in location, and that $269 upfront fee covers the draw, interpretation, and first month of medication. For other programs, whether labs are included in a bundled fee or billed separately isn't publicly stated - that's a question to ask during intake.
Step 3 - Personalized Plan. If your provider determines treatment is appropriate, they build a plan and medication ships through Epiq Scripts. GATLAN describes this as tailored to your biology and your goals - not a one-size protocol.
Step 4 - Ongoing Support. This is the concierge part. GATLAN's hormone optimization page describes unlimited online access to your provider for follow-ups, dosage adjustments, and questions. That's the element most central to how they differentiate from transactional platforms.
One thing worth knowing: GATLAN's own Terms of Service draw a clear line - the platform facilitates connections to licensed providers, but doesn't provide clinical services, diagnosis, or treatment itself. The medical judgment comes entirely from your assigned provider. The platform's role is coordination and logistics.
Buyer Takeaway: From signup to first delivery, you're looking at intake review plus lab scheduling time - it's not instant. Build in a realistic timeline if you're trying to start treatment by a specific date. And confirm whether lab costs are bundled or separate for whatever program you're considering before you commit.
Is GATLAN Legit? What the Publicly Reviewable Details Show
That depends on how you're defining "legitimate." Here's a narrow, verifiable answer - the kind that actually helps you make a decision.
What's publicly verifiable:
Legal business entity: Immortal Male, Inc. is the brand-disclosed operator with a published physical address at 60010 W Spring Creek Pkwy #1012, Plano, TX 75024
Published Terms and Privacy Policy: Both are publicly accessible at gatlan.com with effective dates (Terms last updated March 2026)
Pharmacy partner disclosed: Epiq Scripts is named on the official hormone optimization page
Support channels published: support@gatlan.com and legal@gatlan.com are both live and publicly listed
Chief Medical Advisor's academic credentials: Dr. Robert Lufkin is listed as a Professor at UCLA and USC School of Medicine - faculty affiliations are independently verifiable through university directories
Media coverage: Forbes and Men's Journal are named on the homepage; multiple podcast appearances are listed with nationally recognized hosts
What "legitimate" doesn't tell you: Whether GATLAN is the right clinical fit for your specific goals, whether you'll qualify for the treatment you want, or whether its pricing is the best value for your situation. Those are fit questions, not legitimacy questions - and they're what the free consultation is designed to answer.
One nuance worth naming: GATLAN's own Terms of Service state that the platform doesn't confirm provider credentials or verify provider standing with licensing boards. Provider licensing is regulated by individual state medical boards. If verifying a specific provider's license matters to you, your state's medical board license lookup tool is the authoritative source - not GATLAN's self-reported "100% Licensed Providers" claim, which is brand-reported and hasn't been independently audited by this publication.
Buyer Takeaway: GATLAN has several publicly reviewable business markers, including a disclosed legal operator, published Terms, listed support contacts, a stated pharmacy partner, and brand-stated service availability. Clinical fit, eligibility, pricing, and treatment appropriateness remain separate questions - The clinical fit question is separate - and that's what the free consultation exists to answer.
What Does GATLAN Cost? A Straight Answer on Pricing Transparency
This is probably the most common question people have - and the honest answer is that GATLAN's pricing model isn't built for comparison shopping before you book.
The one publicly stated price: The Kyzatrex oral testosterone program is $269 upfront (covering LabCorp lab draw, provider review, and first month of medication) and $269/month ongoing (covering medication, required maintenance labs, and provider access). That information is published in GATLAN's own support documentation.
Everything else: GLP-1 weight loss programs, women's hormone therapy, peptide protocols, NAD+, hair restoration, and men's wellness support all have consultation-gated pricing. You won't know the cost until you go through intake and receive a personalized plan.
What you should ask before you commit to anything:
What's the total monthly cost for my specific plan, including labs?
Are labs bundled in the monthly fee or billed separately?
What happens to my billing if I'm disqualified after the initial lab review?
What are the exact cancellation steps and deadlines for recurring programs?
How the pricing models compare structurally (verify current pricing directly with each platform before comparing):
Other telehealth platforms in this category use different pricing structures - some offer flat monthly subscriptions, others use diagnostic membership tiers, and some separate medication costs from the consultation fee. Because telehealth pricing changes frequently, a direct numerical comparison with any competitor requires confirming current pricing during intake with that specific platform. The structural difference that is clear: GATLAN's Kyzatrex program bundles labs, medication, and provider access in a single stated fee, whereas some competitors price those components separately. Whether the bundled model costs more or less for your specific protocol depends on what's actually prescribed, which you won't know until after intake.
Buyer Takeaway: At $269/month all-in for Kyzatrex (labs, meds, provider access bundled), GATLAN's stated price sits at the higher end of the oral TRT market - but it's a bundled figure, not just the medication. For GLP-1 and other services, you genuinely won't know your number until the consultation. That's the model's tradeoff.
What Should Patients Know About Compounded Semaglutide and Tirzepatide at GATLAN?
This section matters more than most buyers realize, so let's be direct about it.
GATLAN's weight loss protocols use compounded semaglutide and tirzepatide, prepared by Epiq Scripts, the brand's disclosed pharmacy partner. A patient testimonial published by GATLAN also references compounded tirzepatide by name. The brand is reasonably transparent about this - it's not buried in the fine print.
What they are: Compounded medications are prepared by licensed compounding pharmacies using active pharmaceutical ingredients. They allow customization of dose, delivery format, and concentration in ways that mass-manufactured brand-name products don't. For patients who can't access or afford brand-name options, compounded formulations may be available when applicable federal and state compounding requirements are satisfied.
What compounded medications are not - and this is what you need to understand clearly: Per FDA guidance, compounded drugs are not evaluated by FDA for safety, effectiveness, or quality before they reach patients. That review simply doesn't happen for compounded formulations the way it does for brand-name approved drugs. Wegovy and Zepbound - the brand-name FDA-approved GLP-1 medications - went through full FDA review. Compounded semaglutide and tirzepatide haven't. That's a real distinction, not a technicality.
There's also a dosing-error risk worth naming. Because concentrations can vary between compounding pharmacies and formulations, getting the dose increment wrong is a documented safety concern with compounded injectables. Before you take your first dose, confirm the specific concentration, dose increment, and administration method with your GATLAN provider. Don't assume it's identical to anything you've read about in brand-name clinical trials.
One more open question: GATLAN's publicly available materials don't specify whether Epiq Scripts operates as a 503A traditional compounding pharmacy (patient-specific, smaller scale) or a 503B outsourcing facility (larger scale, additional FDA oversight layers). That classification affects the regulatory framework governing your specific medications. It's a reasonable question to ask your provider during intake.
Buyer Takeaway: Compounded GLP-1 medications through a licensed physician-supervised pharmacy may be available when compounding requirements are met. Going in with clear eyes about what "not FDA-reviewed" means in practice makes you a more informed patient. Ask GATLAN's provider about the pharmacy classification and exact dosing before your first injection - that's not paranoia, that's smart.
What the Evidence Base Shows About GATLAN's Core Services
Here's the honest breakdown of the evidence behind what GATLAN offers - not all protocols carry equal scientific weight, and knowing the difference helps you ask better questions during consultation.
Testosterone replacement therapy (TRT): Testosterone therapy has an established clinical role for appropriately diagnosed testosterone deficiency or hypogonadism, when confirmed through proper evaluation and monitored by a licensed healthcare professional. The NIH and clinical endocrinology guidelines recognize TRT as an appropriate treatment in that context. Eligibility, formulation choice, follow-up labs, fertility considerations, hematocrit monitoring, cardiovascular history, and sleep apnea risk are all factors the prescribing provider should review with you individually.
GATLAN's use of Kyzatrex - an FDA-approved oral testosterone formulation - means that specific product carries formal FDA approval for specific labeled uses in specific indicated populations. That's worth noting. FDA labeling for Kyzatrex also has a specific prescribing requirement: hypogonadism should be confirmed through morning testosterone measurements on at least two separate days before treatment starts. A provider who skips that two-measurement step isn't following the labeled protocol. It's a reasonable question to raise with your provider if Kyzatrex is what they're recommending.
GATLAN's testosterone cypionate injectable program is also listed - testosterone cypionate is among the most widely used TRT formulations, with an established clinical use in appropriate patient populations.
GLP-1 medications for weight loss: The clinical case for GLP-1 receptor agonists in medical weight management has a formal FDA approval history for specific indicated uses, with clinical evidence from large randomized controlled trials supporting those approved indications. Multiple large randomized controlled trials back their efficacy for meaningful weight reduction in adults with obesity or metabolic comorbidities. The caveat - already covered above - is that GATLAN's formulations are compounded versions, not the brand-name FDA-approved products. The FDA-approved versions of those active ingredients have formal clinical and regulatory histories for specific indicated populations; compounded formulations haven't been through that same FDA review process as finished products.
Hormone replacement therapy for women: moderate to strong evidence, with nuance. The evidence base for HRT in menopausal women is substantial, though ongoing research continues to refine guidance on specific formulations, routes of administration, and individual risk profiles. The FDA updated labeling for several menopausal hormone therapy products in 2025 to better reflect current evidence - a sign that this remains an active, evolving space rather than settled science.
Peptide therapy: preliminary evidence tier. The National Center for Complementary and Integrative Health (NCCIH) doesn't currently have formal evidence reviews for most peptides used in longevity or performance contexts. Some specific peptides have meaningful preliminary research behind them; others don't. The evidence depth varies significantly by peptide. If GATLAN's provider recommends a specific peptide protocol, it's worth asking what the evidence basis is for that specific compound - and being comfortable with the answer.
NAD+ and longevity protocols: active research, preliminary in humans. NAD+ precursors have active research programs at major academic centers, and the biology is compelling. Current human evidence is mostly early-stage - small trials, short durations, early findings. The animal data is more robust. Rapamycin for longevity is similarly positioned: genuinely interesting science, real debate in the research community about appropriate human dosing and long-term effects, not yet a mainstream clinical standard.
Buyer Takeaway: TRT and GLP-1 are where GATLAN's service categories sit on different evidence tiers, with testosterone-related care and GLP-1 medications having formal clinical and regulatory histories for specific indicated populations. Peptides and longevity protocols are emerging science territory - not disqualifying, but a different conversation than prescribing Kyzatrex. A good provider should be able to explain the evidence tier of whatever they recommend. That's a test worth running.
View the current GATLAN offer (official GATLAN page)
What Delaying Low Testosterone Treatment May Mean for Your Health
This section isn't urgency framing. It's information that a knowledgeable provider would share with you during an initial consultation - context that matters to an informed decision, whether that decision is to start treatment now, wait six months, or choose a different path entirely.
The clinical literature on untreated testosterone deficiency documents several time-dependent effects that compound over months and years rather than resolving on their own. The NIH and clinical endocrinology guidelines describe these in the context of diagnosed hypogonadism:
Bone mineral density: Testosterone plays a documented role in maintaining bone density in men. Prolonged testosterone deficiency is associated with accelerated bone loss and increased fracture risk - effects that respond to treatment but may not fully reverse depending on duration and severity.
Metabolic function: Testosterone has established effects on insulin sensitivity, body composition, and lipid metabolism. Untreated deficiency in appropriate patients is associated with increased visceral fat accumulation and metabolic markers that respond to treatment in studies of men with diagnosed hypogonadism.
Cardiovascular markers: The relationship between testosterone and cardiovascular health is active research territory. Current clinical guidance recommends individualized risk assessment rather than categorical avoidance - and cardiovascular risk assessment is part of the evaluation a competent provider should conduct before recommending TRT.
Energy, cognitive function, and mood: These are the most commonly reported quality-of-life effects. They're also the most variable and individual. Whether treatment improves them for a specific patient depends on whether the underlying cause is testosterone deficiency - which only proper lab evaluation can confirm.
The point isn't "start treatment immediately." The point is: if you've been researching online testosterone evaluation for more than a few months, the time cost of not knowing whether you qualify has a biological dimension that most articles don't address directly. The consultation itself - even if you ultimately decide not to proceed with treatment - answers the question of whether any of this applies to you personally.
Buyer Takeaway: Delayed evaluation isn't neutral - it's a choice with documented biological implications in patients with actual testosterone deficiency. The free consultation is how you find out whether that applies to you. If it doesn't, you've spent thirty minutes. If it does, you have information that changes what you do next.
GATLAN Enrollment Verification Checklist: What to Confirm Before You Pay Anything
These aren't disqualifiers. They're the things a knowledgeable friend would tell you before you went in.
1. The refund policy is restrictive - know that going in. GATLAN's published Terms of Service are explicit: "refunds are generally not provided," and any refund determination is at GATLAN's "sole and absolute discretion." For the Kyzatrex program, where you're paying $269 upfront before the provider decides whether you qualify, that matters. If you're not a candidate after the lab review, the refund question is governed by this same discretionary policy. Before you pay any upfront fee for any program, email support@gatlan.com and ask specifically: what's the refund process if my provider determines I don't qualify? Get that answer before you pay, not after.
2. Pricing for most services isn't publicly posted. This isn't unusual for premium concierge telehealth - but it does mean you can't comparison shop on numbers alone until you've done the intake. If you're the type of buyer who wants to line up five platforms' monthly costs in a spreadsheet before booking anything, GATLAN's model is going to require more patience than something like TRT Nation or PeterMD, which publish their pricing upfront.
3. Recurring billing is real - confirm cancellation before you start. GATLAN's programs involve recurring billing through Recurly. The FTC announced a Click-to-Cancel rule in 2024, but that rule was vacated by the Eighth Circuit Court of Appeals in July 2025 and isn't currently in effect as a standalone regulation. That said, recurring billing isn't unregulated - it remains subject to FTC Section 5 authority, the Restore Online Shoppers' Confidence Act (ROSCA), and applicable state auto-renewal laws including California Business and Professions Code §17600. Before you start any recurring program, get the exact cancellation steps, the cancellation deadline relative to your next billing cycle, and the renewal terms in writing from GATLAN directly at support@gatlan.com.
Buyer Takeaway: None of these three points should scare you off. They should make you a more prepared buyer who asks the right questions before committing - which is exactly the kind of buyer GATLAN's concierge model should be able to handle well.
The initial consultation carries no charge. Program costs begin after eligibility is determined - the Kyzatrex TRT program starts at $269 upfront, $269/month ongoing; all other program pricing is provided during consultation.
View the current GATLAN offer (official GATLAN page)
How to Read GATLAN's Marketing Language
GATLAN's brand voice goes hard on aspiration - "Stay Young, Stay In the Game," "Optimize your hormones, metabolism, and longevity with science-backed protocols designed for high-performers." That's effective positioning for the audience they're targeting. Here's what those phrases actually mean in buyer terms.
"Science-backed protocols" (brand language): Refers to GATLAN's use of established medications like TRT and GLP-1s that have clinical research behind them. Doesn't mean every service on the menu carries equal evidence depth - as the evidence section above documents, peptide and longevity protocols are in a different tier than TRT and GLP-1.
"Designed for high-performers" (brand positioning): Marketing language describing their target customer, not a clinical eligibility requirement. GATLAN works with a broad range of men and women, not exclusively executives or athletes.
"10,000+ Patients Optimized" (brand-reported): This is a brand-stated figure. It hasn't been independently audited by this publication. Customer ratings and testimonials published on GATLAN's site are brand-reported, not independently verified. Individual results vary significantly based on starting health status, treatment compliance, medications prescribed, diet, exercise, and other factors - and any testimonial you read on GATLAN's own site should be understood in that context.
"100% Licensed Providers" (brand-reported): Provider licensing is regulated by individual state medical boards. GATLAN's own Terms of Service acknowledge the platform doesn't confirm or verify provider credential standing independently. The "100% Licensed" claim is brand-reported and hasn't been independently audited by this publication. If you want to verify a specific provider's license, your state medical board's online lookup tool is the authoritative source.
"White-glove medical experience" (brand language): Describes the concierge positioning - dedicated provider, ongoing relationship, personalized adjustments. It's a service model claim, not a clinical performance guarantee.
Buyer Takeaway: The marketing is effective but interpretable once you know what the phrases map to in practice. Ambitious framing + the verification framework in this article = the full picture you need to make a call.
How GATLAN Compares: Concierge Telehealth vs. Commodity TRT in 2026
The online hormone optimization category has grown enough that you have real choices. Here's how GATLAN fits relative to the main alternatives, based on publicly reported information that may have changed.
GATLAN vs. Hims: Hims leads with standardized protocols, a polished app experience, and accessible pricing for a broad audience. GATLAN is positioning for buyers who want a dedicated provider relationship and a broader clinical menu. Hims is lower friction to start; GATLAN is more personalized by design.
GATLAN vs. Hone Health: Hone positions around comprehensive at-home diagnostics - broad biomarker panels, tiered memberships with published pricing. If you want to see your full hormonal picture before committing to a protocol, Hone's diagnostic-first model is appealing. GATLAN's model assigns your provider first and builds the plan around your intake and labs from there.
GATLAN vs. TRT Nation: TRT Nation publishes more upfront pricing structures on its own site, with medication costs separate from the consultation fee. If you've already confirmed low T and want the lowest all-in monthly cost with transparent pricing, TRT Nation's model is built for that. GATLAN bundles the whole stack - labs, meds, provider - into one fee for Kyzatrex, which at $269/month is higher but also more inclusive.
GATLAN vs. PeterMD: PeterMD publishes its TRT pricing on its own site and positions around straightforward, focused injectable TRT. For buyers who know what they want and don't need hand-holding, that value proposition is clear. GATLAN's model adds the ongoing provider relationship as a differentiator.
Service breadth as a structural differentiator: GATLAN's publicly stated service menu covers TRT, GLP-1 medical weight management, peptide-related care, NAD+ protocols, hair restoration, and women's hormone support - all under one provider relationship. For patients whose goals span more than one category, that breadth reduces the coordination involved across separate platforms. Based on the brand's public-facing materials, GATLAN appears differentiated by service breadth and concierge-style provider continuity - not necessarily by lowest cost or broadest state availability.
Buyer Takeaway: GATLAN sits at the premium-concierge end of the market, not the lowest-cost end. That's not a knock - it's accurate positioning. If the dedicated provider relationship and service breadth are your priorities, it's likely a strong fit. If you want the cheapest monthly rate for a specific, already-identified medication, there are more cost-transparent alternatives.
Where GATLAN Says It Operates: The 44-State Breakdown
GATLAN states that it covers 44 states, as published in the brand's Terms of Service. This publication didn't independently verify state-by-state licensure. Confirm your state's current availability directly at gatlan.com before booking.
The states listed in GATLAN's published Terms: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Pennsylvania, and Wyoming.
States not appearing on the brand's published list include Alaska, Arkansas, Massachusetts, New Mexico, Oregon, and Rhode Island, among others. Coverage can change - always confirm current availability at gatlan.com before scheduling.
Buyer Takeaway: Brand-stated 44-state coverage is broad but not national. If you're in a state not on that list, GATLAN isn't currently an option. Check the official site since coverage status can update.
What Happens After You Book the Free Consultation?
Most reviews skip this part - but the operational reality of what happens after you express interest is exactly what you need to know to set the right expectations.
You'll start with a medical intake questionnaire covering your health history and goals, completed from home. A licensed provider reviews your submission and determines whether labs are needed. For Kyzatrex, that means a LabCorp walk-in order - the $269 upfront covers that draw and interpretation. For other programs, lab cost inclusion varies and isn't publicly stated in advance.
If your provider determines you're a candidate, a personalized plan is built and medication ships through Epiq Scripts. Ongoing access to your provider - for adjustments, questions, and follow-ups - is described on the brand's hormone optimization page as unlimited.
On billing: GATLAN's platform uses Recurly for recurring subscription management. The FTC's Click-to-Cancel rule was announced in 2024 but vacated by the Eighth Circuit in July 2025 - it's not currently in effect. Recurring billing still falls under FTC Section 5, ROSCA, and applicable state auto-renewal laws. Before you start any recurring program, get the exact cancellation procedure confirmed in writing at support@gatlan.com. Don't assume stopping a bank payment counts as cancellation - confirm the actual steps first.
Buyer Takeaway: Low friction to start, real commitment once you're in a recurring program. Know the cancellation process before you hit month two.
Why Telehealth Rules Matter for Testosterone-Related Care in 2026
This section exists because it's the most time-sensitive piece of buyer-relevant information in the entire telehealth hormone category right now - and almost no platform's review content foregrounds it.
Testosterone is a Schedule III controlled substance under the Controlled Substances Act. Under the Ryan Haight Act of 2008, prescribing a Schedule III controlled substance via telemedicine normally requires a prior in-person evaluation. That requirement was suspended during the COVID-19 public health emergency - and has remained suspended through a series of temporary extensions since 2020.
On January 1, 2026, the DEA and HHS published the Fourth Temporary Extension of COVID-era telemedicine prescribing flexibilities (Federal Register doc. 2025-24123, 90 Fed. Reg. 61301), effective January 1, 2026 through December 31, 2026. The rule amends 21 CFR 1307.41 and 42 CFR 12.1. That extension is what currently allows DEA-registered practitioners to prescribe controlled substances via telemedicine to patients who have not yet had an in-person evaluation - provided all conditions of the temporary rule are satisfied.
Here's what matters for your decision: DEA officials have explicitly cited the need to avoid what the agency calls a "telemedicine cliff" - the abrupt disruption in care that would occur if temporary prescribing flexibilities expired without permanent replacements in place. The proposed permanent rules, published by DEA in January 2025, are expected to impose new registration requirements, identity-verification steps, prescription drug monitoring program (PDMP) checks, and recordkeeping obligations. The direction of regulatory travel is toward more friction, not less. That isn't alarmism - it's the documented direction of the proposed rulemaking. When the current window closes and permanent rules take effect, starting online testosterone therapy without any in-person component will likely be more complicated than it is today.
What this means practically: if you've been researching online TRT and haven't started yet, the current access model is simpler than what's coming. That's not manufactured urgency - it's federal regulatory reality, sourced directly from the HHS and DEA announcements.
For GLP-1 medications: a separate and equally active regulatory window exists. In March 2026, FDA issued warning letters to 30 telehealth companies for misleading marketing of compounded GLP-1 products - the largest coordinated enforcement action the telehealth industry has faced since the compounding boom began. The primary violations were claims implying compounded GLP-1s are equivalent to FDA-approved products, and obscuring the identity of the actual compounding pharmacy. GATLAN's published materials don't make those claims (this publication verified them against the warning letter violation patterns), but the enforcement environment means that compounded GLP-1 availability through any platform is subject to change. Additionally, FDA's tirzepatide shortage designation has been contested; compounding eligibility for tirzepatide depends on active shortage status, which has shifted multiple times since 2023. Before enrolling specifically for compounded GLP-1 access, ask GATLAN directly: is the medication you want currently on FDA's active drug shortage list, and what's the current legal basis for compounding it?
The FTC is also paying closer attention to this space than at any point in the past decade. In July 2025, the FTC reached a final consent order against NextMed, a telehealth platform, for advertising "only $79 for your first month" without disclosing medication costs, lab fees, mandatory membership terms, and early-termination fees. In March 2026, the FTC launched a dedicated Healthcare Task Force coordinating consumer protection, competition, and technology enforcement specifically targeting health claims substantiation, pricing transparency, endorsement authenticity, and sensitive health data handling. Any telehealth platform operating in 2026 is operating under heightened regulatory scrutiny on all of these dimensions simultaneously.
None of this is a reason to avoid GATLAN. It's context for why understanding the current regulatory framework before you enroll matters more in 2026 than it did two years ago. Prospective patients should confirm the current federal telemedicine framework, any in-person evaluation requirements, state-specific rules, and GATLAN's own current process with the platform directly before starting any long-term protocol.
Buyer Takeaway: The current telehealth TRT access window - no prior in-person visit required - runs through December 31, 2026 under DEA's fourth temporary extension. Permanent rules in development are expected to add friction. The compounded GLP-1 window is even more fluid, tied to FDA shortage designations and active enforcement. If either of these protocols is on your radar, confirming the current regulatory framework and GATLAN's current process directly with the platform before enrolling is a practical first step.
How This Review Was Built - and What It Cannot Tell You
This review is built on publicly available materials: the official GATLAN website (gatlan.com), the brand's published Terms of Service (effective November 2024, last updated March 2026), GATLAN's published support documentation (Kyzatrex pricing), official service pages including the Hormone Optimization, Weight Loss, Women's Path, and LDN pages, and category-level telehealth market research for competitive context.
This publication hasn't received compensated product samples, hasn't interviewed GATLAN or Immortal Male, Inc. personnel, hasn't been granted access to internal protocols or provider training materials, and hasn't conducted independent laboratory testing or clinical outcome auditing. Claims described as "according to the brand" or "brand-stated" reflect publicly published statements - not independently substantiated by this publication.
Last Updated: May 2026
Buyer Takeaway: The gaps in this review - GLP-1 pricing, women's path cost, 503A vs. 503B pharmacy classification, lab cost inclusion details for non-Kyzatrex programs - are real gaps. Filling them is the job of your free consultation, not this article.
Start Your GATLAN Evaluation Here
If you've read this far, you've got the full picture: what's publicly verifiable, what's brand-stated, what the evidence base looks like for each service, what the pricing model means in practice, and what to confirm before you commit to anything. The next step is the free consultation - no posted prices for most services, no upfront commitment for the initial booking.
View the current GATLAN offer (official GATLAN page)
Go in with these three questions ready: What does my specific plan cost all-in, including labs? What's the refund process if I'm not a candidate? What's the exact cancellation procedure for recurring billing?
Frequently Asked Questions About GATLAN
Is GATLAN a legitimate telehealth company?
GATLAN has several publicly reviewable business markers - a disclosed legal operator (Immortal Male, Inc.), with a brand-disclosed business address in Plano, TX. The platform states it covers 44 states - this publication didn't independently verify state-by-state licensure. Epiq Scripts is named as the pharmacy partner on the official site. Published Terms of Service, Privacy Policy, and support contacts are all publicly accessible. Dr. Robert Lufkin's faculty positions at UCLA and USC are independently verifiable. "Legitimate" in this context means: legal operator identified, public terms published, pharmacy partner disclosed, support channels live. It doesn't mean clinical superiority or the right fit for your specific situation - those are separate questions the consultation answers.
What does GATLAN cost?
The only publicly stated price for a specific program is $269/month for Kyzatrex oral testosterone - $269 upfront covering LabCorp labs, provider review, and first month of medication, then $269/month ongoing including labs, medication, and provider access. All other programs - GLP-1 weight loss, women's hormone therapy, peptides, NAD+, hair restoration - require a free consultation before pricing is provided. That's a different model than platforms like TRT Nation or PeterMD, which publicly post starting prices. If having a number before you book is important to you, Kyzatrex is the one service you can evaluate on price today without going through intake.
Does GATLAN use compounded medications?
Yes - the brand discloses this. GATLAN's weight loss protocols use compounded semaglutide and tirzepatide through Epiq Scripts. Per FDA guidance, compounded drugs aren't evaluated by FDA for safety, effectiveness, or quality before they reach patients. That's different from brand-name Wegovy or Zepbound, which have gone through full FDA approval. Dosing errors are a documented risk with compounded injectables - confirm the specific concentration and dose increment with your GATLAN provider before your first dose. Also worth asking: whether Epiq Scripts operates as a 503A or 503B pharmacy, since that affects the regulatory framework governing what you receive.
How many states does GATLAN cover?
GATLAN states it covers 44 states and the District of Columbia, as published in the brand's Terms of Service. This publication didn't independently verify state-by-state licensure. The states appearing on the brand's published list include Alabama, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Pennsylvania, Wyoming, and DC. Confirm your state's current availability at gatlan.com before booking.
What is GATLAN's refund policy?
GATLAN's published Terms of Service state that "refunds are generally not provided" and that any refund is at GATLAN's "sole and absolute discretion" on a case-by-case basis. For the Kyzatrex program, where $269 is collected upfront before the provider determines your eligibility, this policy means you may not get that money back if you don't qualify. Before you pay any upfront fee, contact support@gatlan.com and ask specifically what the refund process is if you're disqualified. Get that answer in writing before you commit.
Who is Dr. Robert Lufkin and what's his role at GATLAN?
Dr. Robert Lufkin is listed on GATLAN's official site as Chief Medical Advisor and is identified as a Professor at UCLA and USC School of Medicine. His faculty affiliations are independently verifiable through university directories. His specific role in GATLAN's clinical protocol design, provider oversight, or day-to-day operations isn't described in detail in publicly available materials. This publication references his credentials as brand-disclosed information; his association with GATLAN is brand-stated. Whether Dr. Lufkin receives compensation in any form - salary, equity, advisory fees, or other consideration - in connection with his Chief Medical Advisor role isn't disclosed in publicly available GATLAN materials. Under FTC 16 CFR Part 255, material connections between endorsers and brands require disclosure. Buyers who consider this material to their decision should ask GATLAN directly.
What's GATLAN's pharmacy partner?
Epiq Scripts is published on GATLAN's official hormone optimization page as its pharmacy partner. That's the compounding pharmacy through which prescribed medications are dispensed and delivered. The specific regulatory classification of Epiq Scripts - 503A traditional compounding pharmacy vs. 503B outsourcing facility - isn't disclosed in publicly available GATLAN materials as of this writing. That classification matters because it affects the regulatory oversight framework for your medications. Ask your provider during intake.
Does GATLAN accept insurance?
The official GATLAN site states "No insurance required." That doesn't automatically answer whether reimbursement, HSA/FSA use, superbills, or other payment options may apply to specific programs. Prospective patients should confirm payment options - including HSA or FSA applicability - directly with GATLAN at support@gatlan.com before enrolling.
What medications does GATLAN prescribe?
Based on published service pages: Kyzatrex (FDA-approved oral testosterone), testosterone cypionate (injectable), compounded semaglutide and tirzepatide (for weight loss), LDN, and various peptides and hormone formulations. The brand notes that all protocols are determined by the assigned licensed provider based on labs, health history, and goals - not every listed medication is available to every patient. All prescriptions require provider evaluation and approval before anything ships.
How is GATLAN different from Hims, Hone, or TRT Nation?
The model difference comes down to the provider relationship. GATLAN assigns a dedicated provider to each patient for ongoing care - adjustments, check-ins, evolving protocols over time. Hims runs a more standardized, high-volume model at lower price points. Hone leads with comprehensive at-home diagnostics and published tiered pricing. TRT Nation positions on transparent flat-rate pricing for a focused TRT menu. GATLAN's service breadth - TRT, GLP-1, women's hormones, peptides, longevity, hair - is also broader than most single-category competitors. Whether that breadth and the concierge model justify the premium is the evaluation each buyer needs to make based on their own goals.
What happens if I'm not eligible for treatment after the intake?
If your provider determines treatment isn't appropriate, no prescription is issued. For the Kyzatrex program, where $269 is paid before that determination, the refund question falls under GATLAN's discretionary refund policy - "generally not provided," per the published Terms. Before any upfront payment, confirm the disqualification refund process directly with GATLAN at support@gatlan.com, and get it in writing.
What Does GATLAN's Privacy Policy Say About Health Data Handling?
GATLAN's privacy policy - labeled "HIPPA Privacy Policy" on the site (note: the correct federal acronym is HIPAA) - governs how the platform handles patient health data. The Terms describe data sharing with healthcare providers and third parties per the Privacy Policy. This publication doesn't make a legal compliance determination. Buyers with specific data privacy questions should review the published Privacy Policy at gatlan.com and direct questions to support@gatlan.com before submitting health information.
Can women use GATLAN?
Yes. GATLAN's published Women's Path page describes personalized hormone optimization (estrogen, progesterone), medical weight loss via GLP-1 medications, thyroid evaluation, and longevity support. Women's path pricing isn't publicly posted - same consultation-gated approach as most of the men's menu. The Women's Path page is accessible at gatlan.com.
How do I cancel a GATLAN subscription?
GATLAN uses Recurly for billing management, and the Terms describe recurring billing for ongoing programs. The FTC's Click-to-Cancel rule - announced in 2024 - was vacated by the Eighth Circuit in July 2025 and isn't currently in effect. That said, recurring billing still falls under FTC Section 5 authority, ROSCA, and applicable state auto-renewal laws including California BPC §17600. To cancel, contact GATLAN directly at support@gatlan.com before your next billing cycle. Don't assume stopping your bank payment or closing a Recurly account constitutes proper cancellation - confirm the exact process with GATLAN in writing before you need to use it.
Where can I review GATLAN's full terms before signing up?
GATLAN's Terms of Service (effective November 2024, last updated March 2026) and Privacy Policy are accessible at gatlan.com via the footer. The Terms include the refund policy, mandatory arbitration clause (which waives jury trial rights and class action participation), the 18+ age requirement, brand-stated state coverage, and the explicit disclaimer that GATLAN doesn't provide medical advice directly - the licensed provider does. Reading the Terms before committing to any paid program is worth the time. Legal questions about the Terms go to legal@gatlan.com.
What are the known risks of TRT and GLP-1 medications?
Your GATLAN provider should walk through these with you during consultation - but here's what the clinical literature documents. For TRT: cardiovascular considerations (especially in older men or those with pre-existing heart conditions), fertility suppression (testosterone therapy reduces sperm production; enclomiphene is sometimes used as a fertility-preserving alternative), hematocrit elevation requiring monitoring, and potential worsening of sleep apnea. For GLP-1 medications: common GI side effects (nausea, vomiting, diarrhea, constipation) that typically peak during dose escalation, documented pancreatitis risk, and a potential association with thyroid C-cell tumors observed in animal studies - which is why individuals with personal or family history of thyroid cancer or MEN2 syndrome are contraindicated. These aren't reasons to avoid treatment. They're reasons to have a thorough clinical conversation with your provider before you start.
Can I still get an online TRT prescription without an in-person visit in 2026?
Yes - for now. The DEA and HHS published a fourth temporary extension of COVID-era telemedicine prescribing flexibilities on January 1, 2026 (90 Fed. Reg. 61301), which remains in effect through December 31, 2026. That extension is what permits Schedule III controlled substances like testosterone to be prescribed via telehealth without a prior in-person evaluation. After December 31, 2026, the current temporary framework expires and permanent rules - which are being finalized and are expected to impose additional requirements including new provider registration, identity-verification steps, and PDMP checks - will govern. The direction of the proposed permanent rules is toward more friction, not less. If you've been researching online TRT, the current access model is simpler than what's likely coming.
Is GATLAN's compounded GLP-1 access still available, and will it remain available?
Compounded GLP-1 access through any telehealth platform - including GATLAN - depends on whether the underlying medication is on FDA's active drug shortage list, since shortage status is the legal basis for 503A/503B compounding eligibility. FDA's tirzepatide shortage designation has been contested; semaglutide shortage status has fluctuated. In March 2026, FDA issued warning letters to 30 telehealth companies for misleading compounded GLP-1 marketing, signaling intensified enforcement in this category. GATLAN hasn't been publicly identified as a recipient of one of those letters, but before enrolling for compounded GLP-1 access, ask GATLAN directly: Is this specific medication currently on FDA's active shortage list? What is the current legal basis for compounding it? What is Epiq Scripts' regulatory classification (503A vs. 503B)? Those three questions determine whether your access is on solid ground.
What happens to online TRT access after December 31, 2026?
After December 31, 2026, the DEA's Fourth Temporary Extension expires. What replaces it will be the permanent regulatory framework currently being finalized, including the proposed Special Registration for Telemedicine rule published by DEA in January 2025. That proposed rule would create a permanent pathway for telemedicine prescribing of controlled substances without an in-person visit - but would also require new DEA special registrations for telehealth providers, identity-verification protocols, PDMP integration requirements, and recordkeeping obligations. In practical terms: telehealth TRT access shouldn't disappear after December 2026, but the compliance infrastructure required to provide it will be heavier, and the transition period may create disruptions in service availability. Confirm with GATLAN how they're planning for the post-2026 regulatory environment before you start a long-term protocol.
Is the affiliate link on this page compensated?
Yes. This article contains an affiliate link to GATLAN's consultation page. If you enroll through that link, this publication may earn a commission at no additional cost to you. That relationship doesn't influence what's written here - the refund policy disclosure, the compounded medication buyer education, the Click-to-Cancel correction, and the pricing transparency gaps are all present regardless. Disclosure is provided in accordance with FTC 16 CFR Part 255.
What No Other GATLAN Review Tells You: The Full Picture Before You Decide
You now have the full picture: GATLAN's publicly reviewable business markers are disclosed and verifiable. Its concierge model is a real differentiator if an ongoing provider relationship is what you're after. Its pricing is consultation-gated for most services. Compounded GLP-1 medications may be available only when applicable federal and state compounding requirements are satisfied - and they are not FDA-approved finished drug products. Its refund policy is restrictive. Its Click-to-Cancel rule reference needs the July 2025 vacatur context. And its "100% Licensed Providers" claim is brand-reported, not independently verified.
If that's the platform you want to explore: start with the free consultation, bring your questions, and know your cancellation process before you commit to anything recurring.
View the current GATLAN offer (official GATLAN page)
Contact and Support
Official site: gatlan.com
Patient support: support@gatlan.com
Legal and disputes: legal@gatlan.com
Mailing address (brand-disclosed): Immortal Male, Inc., 60010 W Spring Creek Pkwy #1012, Plano, TX 75024
View the current GATLAN offer (official GATLAN page)
Disclaimers
FDA Medical Disclaimer. The statements in this article haven't been evaluated by the Food and Drug Administration. GATLAN's services facilitate access to licensed medical professionals and prescription medications. This article is not intended to diagnose, treat, cure, or prevent any disease. Prescription medications require evaluation and approval by a licensed provider before any prescription is issued. Compounded medications referenced in this article - including compounded semaglutide and tirzepatide - are not FDA-approved finished drug products. Per FDA guidance, FDA does not evaluate compounded drugs for safety, effectiveness, or quality before they reach patients. Individual results vary. Consult a licensed healthcare provider before starting any hormone therapy, weight management medication, or other prescription treatment.
FTC 16 CFR Part 255 - Testimonial and Endorsement Disclosure. Customer testimonials referenced in this article reflect individual experiences reported on GATLAN's official site. Customer ratings and testimonials are brand-reported, not independently audited by this publication. Individual experiences vary significantly based on starting health status, treatment compliance, medications prescribed, diet, exercise, and other factors. Testimonials don't constitute guarantees of similar results. GATLAN's published testimonials identify individuals in first-name, last-initial format. This publication cannot confirm whether these represent real patient names or pseudonyms. Under FTC 16 CFR Part 465, testimonials using fictional names require disclosure. Buyers should treat all testimonials as illustrative of stated experiences, not guaranteed outcomes.
FTC 16 CFR Part 465 - Consumer Review Fairness. This publication doesn't solicit, incentivize, or publish reviews on behalf of GATLAN. No aggregate review scores from third-party platforms have been independently audited by this publication. The brand's stated "10,000+ Patients Optimized" figure is brand-reported and hasn't been independently verified.
Compounded Medication Disclosure. GATLAN's weight loss protocols use compounded semaglutide and tirzepatide through Epiq Scripts. Per FDA guidance, compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing. Dosing errors are a documented risk with compounded injectables. Confirm concentration, dose increments, and administration instructions with your prescribing provider before use. The regulatory classification of Epiq Scripts (503A vs. 503B) isn't confirmed in publicly available GATLAN materials as of this writing.
Recurring Billing and Negative-Option Disclosure. GATLAN's programs include recurring billing managed through Recurly. Recurring subscriptions are subject to applicable federal and state negative-option, auto-renewal, and unfair or deceptive practices laws. The FTC's Click-to-Cancel rule was announced in 2024 and vacated by the Eighth Circuit Court of Appeals in July 2025 - it isn't currently in effect as a standalone regulation. Recurring billing remains subject to FTC Section 5 authority, ROSCA, and applicable state auto-renewal laws including California Business and Professions Code §17600. Confirm specific cancellation steps and renewal terms at support@gatlan.com before enrolling in any recurring program.
Telehealth Service Disclosure. GATLAN is operated by Immortal Male, Inc. The platform facilitates connections between patients and licensed medical providers but doesn't directly provide clinical services, medical diagnoses, or treatment. Per GATLAN's published Terms, the platform doesn't confirm provider credentials or verify licensing board standing. Provider licensing is regulated by individual state medical boards. Buyers who want to verify a specific provider's license can use the relevant state medical board's online lookup tool.
Pricing and Terms Accuracy. This article reflects information available as of May 2026. The $269/month Kyzatrex pricing is sourced from GATLAN's published support documentation. All other pricing requires direct consultation with GATLAN. Competitor platforms referenced in this article use different pricing structures; verify current pricing directly with each platform. Pricing, program availability, state coverage, pharmacy partnerships, and Terms of Service are subject to change without notice. Rely on gatlan.com as the authoritative source before any purchase or enrollment decision.
Geographic and Jurisdiction Disclosure. GATLAN states it covers 44 U.S. states and DC, as published in the brand's Terms of Service. This publication didn't independently verify state-by-state licensure. GATLAN's Terms are governed by Delaware law. Dispute resolution is subject to mandatory arbitration through AHLA; users waive jury trial rights and class action participation by accepting the Terms. A 30-day opt-out window exists: contact legal@gatlan.com within 30 days of first accepting the Terms to preserve jury trial and class action rights. GATLAN doesn't appear to operate outside the United States based on published coverage information. Additionally, GATLAN's published Terms of Service state that by using the platform, users are also bound by Google's Terms of Service. Buyers with questions about how health data interfaces with any third-party technology services should review both GATLAN's Privacy Policy and Google's Terms before submitting health information.
HIPAA and Health Data Disclosure. GATLAN's handling of patient health information is governed by the brand's published Privacy Policy at gatlan.com. GATLAN's published Terms of Service also state that by using the platform, users are bound by Google's Terms of Service - meaning health data may flow through Google-infrastructure services alongside GATLAN's own privacy framework. Buyers with specific questions about third-party data handling should review both GATLAN's Privacy Policy and Google's Terms of Service before submitting health information through the platform. This publication doesn't independently assess HIPAA compliance.
Third-Party Consumer Feedback Platforms. This article references third-party feedback platforms in general category terms only. This publication doesn't endorse, audit, or accept responsibility for the accuracy of reviews on any third-party platform. Evaluate third-party reviews critically, look for verified-purchase indicators where available, and weigh reviewer context against your own situation.
Forward-Looking Statements and Article Accuracy. This article reflects information available as of May 2026 and was prepared with reasonable care to be accurate and useful at time of publication. Pricing, state coverage, pharmacy partnerships, refund terms, contact information, and customer data may change after publication without notice. No representation is made that information will remain accurate in the future. Rely on the official GATLAN website as the authoritative source for current product information before any purchase or enrollment decision.
Material Limitations of This Review. This review is based exclusively on publicly available materials including the official GATLAN website, published Terms of Service, published support documentation, and category-level market research. This publication hasn't received compensated samples, hasn't interviewed GATLAN personnel, hasn't accessed internal clinical protocols, and hasn't conducted independent laboratory testing or clinical outcome auditing. Claims described as "brand-stated," "brand-disclosed," or "brand-reported" reflect publicly published statements and haven't been independently substantiated by this publication. Buyers should verify any claim that materially affects their enrollment decision by contacting GATLAN at support@gatlan.com.
Trademark Acknowledgment. "GATLAN" is a brand name used in this article for product identification purposes. A review of the official GATLAN website as of May 2026 didn't confirm a registered trademark symbol (®) on the brand name. The ® symbol is accordingly not applied. All brand names mentioned are the property of their respective owners and are used for editorial identification only.
Reasonable Consumer Standard. This article is written for a general adult consumer audience and intends statements to be interpreted as a reasonable consumer would interpret them in context. Attribution language such as "brand-stated," "brand-disclosed," "according to the brand," or "per the published Terms" identifies claims that haven't been independently verified by this publication. Marketing language published on GATLAN's official site - including "science-backed protocols designed for high-performers," "10,000+ Patients Optimized," "100% Licensed Providers," and similar phrases - is explicitly identified in this article as brand-asserted marketing language and isn't represented as independently verified performance data, third-party rankings, or laboratory-confirmed outcomes by this publication.
Publisher Relationship Disclosure. This article was prepared as an paid advertorial. The publisher isn't affiliated with GATLAN, Immortal Male, Inc., Epiq Scripts, or any other entity named in this article. Inclusion of an affiliate link doesn't imply endorsement or warranty of GATLAN's services.
SOURCE: GATLAN
Source: GATLAN
